Clinical Trials Browser

Carcinoma, Basal Cell × Methotrexate × Clear all

NCT05315128 2022-04-07

Intralesional Versus Intramuscular Methotrexate for Non-melanoma Skin Cancers

Phase 2 Completed

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Keratoacanthoma